Form 8-K - Current report:
SEC Accession No. 0000950170-22-026871
Filing Date
2022-12-21
Accepted
2022-12-21 16:31:06
Documents
14
Period of Report
2022-12-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K thrd-20221216.htm   iXBRL 8-K 70136
2 EX-3.1 AMENDED AND RESTATED BYLAWS OF THE COMPANY thrd-ex3_1.htm EX-3.1 358180
  Complete submission text file 0000950170-22-026871.txt   624356

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thrd-20221216_lab.xml EX-101.LAB 16612
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrd-20221216_def.xml EX-101.DEF 13241
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrd-20221216_pre.xml EX-101.PRE 12563
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrd-20221216.xsd EX-101.SCH 2916
8 EXTRACTED XBRL INSTANCE DOCUMENT thrd-20221216_htm.xml XML 6194
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 415-215-6023
Third Harmonic Bio, Inc. (Filer) CIK: 0001923840 (see all company filings)

IRS No.: 834553503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41498 | Film No.: 221478791
SIC: 2834 Pharmaceutical Preparations